Article
Immune phenotypes predict survival in patients with glioblastoma multiforme
1 Sept 2016
Abstract excerpt
BACKGROUND: Glioblastoma multiforme (GBM), a common primary malignant brain tumor, rarely disseminates beyond the central nervous system and has a very bad prognosis. The current study aimed at the analysis of immunological control in individual patients with GBM. METHODS: Immune phenotypes and plasma biomarkers of GBM patients were determined at the time of diagnosis using flow cytometry and ELISA, respectively....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
